Jeffrey Yordon, Chief Executive Officer at Sagent Pharmaceuticals, Inc. (SGNT), sold 85,813 shares at $20.03 ($1.7M) on 2013-09-16, disclosed to the SEC on 2013-09-17.
Open-market sale of $1.7M SGNT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATNX | BUY | 2018-03-26 | $73K | — | Filing → |